145 related articles for article (PubMed ID: 31838771)
21. Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease.
Goto H; Sugita K; Yamamoto O
Indian J Dermatol; 2021; 66(2):169-173. PubMed ID: 34188273
[TBL] [Abstract][Full Text] [Related]
22. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
24. Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease.
Sato Y; Fujimura T; Tanita K; Chunbing L; Matsushita S; Fujisawa Y; Otsuka A; Yamamoto Y; Hidaka T; Aiba S
Exp Dermatol; 2019 Aug; 28(8):933-939. PubMed ID: 31001887
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
26. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
[TBL] [Abstract][Full Text] [Related]
27. The expression of EpCAM in extramammary Paget's disease.
Yamada-Kanazawa S; Tasaki Y; Kajihara I; Sakamoto R; Maeda-Otsuka S; Ihn H
Intractable Rare Dis Res; 2019 Feb; 8(1):20-23. PubMed ID: 30881853
[TBL] [Abstract][Full Text] [Related]
28. RANKL-Expressing Ectopic Extramammary Paget's Disease on the Lower Abdomen.
Hagiwara-Takita A; Fujimura T; Kakizaki A; Aiba S
Case Rep Dermatol; 2016; 8(2):130-5. PubMed ID: 27462221
[TBL] [Abstract][Full Text] [Related]
29. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
30. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
31. Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.
Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Aiba S
Br J Dermatol; 2017 Feb; 176(2):387-394. PubMed ID: 27411503
[TBL] [Abstract][Full Text] [Related]
32. Methylation and expression analysis of mismatch repair genes in extramammary Paget's disease.
Kang Z; Zhu Y; Zhang QA; Dong L; Xu F; Zhang X; Guan M
J Eur Acad Dermatol Venereol; 2019 May; 33(5):874-879. PubMed ID: 30784122
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of mucin genes in mammary and extramammary Paget's disease.
Kuan SF; Montag AG; Hart J; Krausz T; Recant W
Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
[TBL] [Abstract][Full Text] [Related]
34. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
35. Potential diagnostic utility of CDX-2 immunophenotyping in extramammary Paget's disease.
Zeng HA; Cartun R; Ricci A
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):342-6. PubMed ID: 16280663
[TBL] [Abstract][Full Text] [Related]
36. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
37. Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments.
Ishizuki S; Nakamura Y
Curr Oncol; 2021 Aug; 28(4):2969-2986. PubMed ID: 34436026
[TBL] [Abstract][Full Text] [Related]
38. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
40. P16 Expression in Extramammary Paget's Disease of the Vulva and Scrotum Is Not Human Papillomavirus Related.
Al-Obaidy KI; Kao CS; Idrees MT
Int J Surg Pathol; 2018 Oct; 26(7):617-620. PubMed ID: 29745285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
